OBJECTIVES: In September 1999, the Elizabeth Glaser Pediatric AIDS Foundation initiated a multicountry, service-based programmatic effort in the developing world to reduce perinatally acquired HIV infection. We review 6(1/2) years of one of the world's largest programs for the prevention of mother-to-child transmission (PMTCT) of HIV. METHODS: Each PMTCT facility records patient data in antenatal clinics and labor and delivery settings about counseling, testing, HIV status, and antiretroviral prophylaxis and submits the data to foundation staff. RESULTS: More than 2.6 million women have accessed foundation-affiliated services through June 2006. Overall, 92.9% of women who received antenatal care or were eligible for PMTCT services in labor and delivery have been counseled, and 82.8% of those counseled accepted testing. Among women identified as HIV positive, 75.0% received antiretroviral prophylaxis (most a single dose of nevirapine), as did 45.6% of their infants. CONCLUSIONS: The foundation's experience has demonstrated that opt-out testing, supplying mothers with medication at time of diagnosis, and providing the infant dose early have measurably improved program efficiency. PMTCT should be viewed as an achievable paradigm and an essential part of the continuum of care.
OBJECTIVES: In September 1999, the Elizabeth Glaser Pediatric AIDS Foundation initiated a multicountry, service-based programmatic effort in the developing world to reduce perinatally acquired HIV infection. We review 6(1/2) years of one of the world's largest programs for the prevention of mother-to-child transmission (PMTCT) of HIV. METHODS: Each PMTCT facility records patient data in antenatal clinics and labor and delivery settings about counseling, testing, HIV status, and antiretroviral prophylaxis and submits the data to foundation staff. RESULTS: More than 2.6 million women have accessed foundation-affiliated services through June 2006. Overall, 92.9% of women who received antenatal care or were eligible for PMTCT services in labor and delivery have been counseled, and 82.8% of those counseled accepted testing. Among women identified as HIV positive, 75.0% received antiretroviral prophylaxis (most a single dose of nevirapine), as did 45.6% of their infants. CONCLUSIONS: The foundation's experience has demonstrated that opt-out testing, supplying mothers with medication at time of diagnosis, and providing the infant dose early have measurably improved program efficiency. PMTCT should be viewed as an achievable paradigm and an essential part of the continuum of care.
Authors: N Shaffer; R Chuachoowong; P A Mock; C Bhadrakom; W Siriwasin; N L Young; T Chotpitayasunondh; S Chearskul; A Roongpisuthipong; P Chinayon; J Karon; T D Mastro; R J Simonds Journal: Lancet Date: 1999-03-06 Impact factor: 79.321
Authors: Marc Bulterys; Mary Glenn Fowler; Nathan Shaffer; Pius M Tih; Alan E Greenberg; Etienne Karita; Hoosen Coovadia; Kevin M De Cock Journal: BMJ Date: 2002-01-26
Authors: W Andiman; Y Bryson; M de Martino; M Fowler; D Harris; C Hutto; B Korber; A Kovacs; S Landesman; M Lindsay; N Lapointe; L Mandelbrot; M-L Newell; H Peavy; J Read; C Rudin; A Semprini; R Simonds; R Tuomala Journal: N Engl J Med Date: 1999-04-01 Impact factor: 91.245
Authors: P Musoke; L A Guay; D Bagenda; M Mirochnick; C Nakabiito; T Fleming; T Elliott; S Horton; K Dransfield; J W Pav; A Murarka; M Allen; M G Fowler; L Mofenson; D Hom; F Mmiro; J B Jackson Journal: AIDS Date: 1999-03-11 Impact factor: 4.177
Authors: Tabitha Sripipatana; Allison Spensley; Anna Miller; James McIntyre; Gloria Sangiwa; Frederick Sawe; David Jones; Catherine M Wilfert Journal: Am J Obstet Gynecol Date: 2007-09 Impact factor: 8.661
Authors: Alejandro Dorenbaum; Coleen K Cunningham; Richard D Gelber; Mary Culnane; Lynne Mofenson; Paula Britto; Claire Rekacewicz; Marie-Louise Newell; Jean Francois Delfraissy; Bethann Cunningham-Schrader; Mark Mirochnick; John L Sullivan Journal: JAMA Date: 2002-07-10 Impact factor: 56.272
Authors: Elizabeth M Stringer; Moses Sinkala; Jeffrey S Stringer; Elizabeth Mzyece; Ida Makuka; Robert L Goldenberg; Pascal Kwape; Martha Chilufya; Sten H Vermund Journal: AIDS Date: 2003-06-13 Impact factor: 4.177
Authors: L Mandelbrot; J Le Chenadec; A Berrebi; A Bongain; J L Bénifla; J F Delfraissy; S Blanche; M J Mayaux Journal: JAMA Date: 1998-07-01 Impact factor: 56.272
Authors: Carla J Chibwesha; Mark J Giganti; Nande Putta; Namwinga Chintu; Jessica Mulindwa; Benjamin J Dorton; Benjamin H Chi; Jeffrey S A Stringer; Elizabeth M Stringer Journal: J Acquir Immune Defic Syndr Date: 2011-10-01 Impact factor: 3.731
Authors: Maureen Braun; Mark M Kabue; Eric D McCollum; Saeed Ahmed; Maria Kim; Leela Aertker; Marko Chirwa; Michael Eliya; Innocent Mofolo; Irving Hoffman; Peter N Kazembe; Charles van der Horst; Mark W Kline; Mina C Hosseinipour Journal: J Acquir Immune Defic Syndr Date: 2011-04-15 Impact factor: 3.731
Authors: Ronaldo I Moreira; Paula M Luz; Claudio J Struchiner; Mariza Morgado; Valdilea G Veloso; Jeanne C Keruly; Beatriz Grinsztejn; Richard D Moore Journal: J Acquir Immune Defic Syndr Date: 2011-08 Impact factor: 3.731
Authors: A E Ezeamama; C Duggan; K P Manji; D Spiegelman; E Hertzmark; R J Bosch; R Kupka; J O Okuma; R Kisenge; S Aboud; W W Fawzi Journal: HIV Med Date: 2013-11-11 Impact factor: 3.180
Authors: Leigh M Howard; José A Tique; Sandra Gaveta; Mohsin Sidat; Russell L Rothman; Sten H Vermund; Philip J Ciampa Journal: AIDS Date: 2014-04-24 Impact factor: 4.177
Authors: Eric D McCollum; Geoffrey A Preidis; Mark M Kabue; Emmanuel B M Singogo; Charles Mwansambo; Peter N Kazembe; Mark W Kline Journal: PLoS One Date: 2010-03-10 Impact factor: 3.240
Authors: Adam R Aluisio; Rose Bosire; Betz Bourke; Ann Gatuguta; James N Kiarie; Ruth Nduati; Grace John-Stewart; Carey Farquhar Journal: J Acquir Immune Defic Syndr Date: 2016-10-01 Impact factor: 3.731
Authors: Jeffrey S A Stringer; Michelle S McConnell; James Kiarie; Omotayo Bolu; Thanomsak Anekthananon; Tavatchai Jariyasethpong; Dara Potter; Winnie Mutsotso; Craig B Borkowf; Dorothy Mbori-Ngacha; Peter Muiruri; John Odero Ong'ech; Isaac Zulu; Lungowe Njobvu; Bongkoch Jetsawang; Sonal Pathak; Marc Bulterys; Nathan Shaffer; Paul J Weidle Journal: PLoS Med Date: 2010-02-16 Impact factor: 11.069